Đang chuẩn bị liên kết để tải về tài liệu:
Single dose of dexamethasone is not associated with postoperative recurrence and mortality in breast cancer patients: A propensity-matched cohort study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Dexamethasone is widely used in cancer patients despite the concern that perioperative glucocorticoids may potentially cause immunosuppression. However, studies on the influence of dexamethasone on cancer recurrence after curative surgery have produced conflicting results. | Single dose of dexamethasone is not associated with postoperative recurrence and mortality in breast cancer patients A propensity-matched cohort study

TÀI LIỆU LIÊN QUAN

Pharmacokinetics of marbofloxacin following single and repeated dose intravenous administration in broiler chickens

Disposition kinetics of Cefquinome in calves after a single intramuscular Bolus dose

A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

Efficacy of single-dose dexmedetomidine combined with low-dose remifentanil infusion for cough suppression compared to high-dose remifentanil infusion: A randomized, controlled, non inferiority trial

Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors

Exploring the behaviour of luminescence signals from feldspars: Implications for the single aliquot regenerative dose protocol

Single and multi-grain OSL investigations in the high dose range using coarse quartz

Báo cáo khoa học: " In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction 192 Ir high-dose-rate brachytherapy"

Abediterol, a novel long-acting β2-agonist: Bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.